clinical research prime

Yeast Infection Study

Vulvovaginal Atrophy Treatment

  • Females between the ages of 21 – 66.
  • The pivotal IDE study to evaluate effectiveness and safety, of the Madorra Therapy System in women with a diagnosis of Vulvovaginal Atrophy.
  • Participants will receive study related treatment at no cost and will be compensated for time and travel.